May 07, 2018
Monsanto Company Chairman And Chief Executive Officer Hugh Grant Announces Intent To Leave Monsanto Upon Closing Of Bayer Acquisition
Apr 17, 2018
Preclinical Data Presented by Bayer at AACR Highlights BAY 1905254, Formerly the CGEN-15001T Program, Efficacy in Cancer Immunotherapy
Mar 08, 2018
The Society for Reproductive Investigation and Bayer Announce Discovery and Innovation Grant Recipients
Jan 19, 2018
WWII Soviet bomber parts found in lake near Auschwitz
Dec 22, 2017
Global Contraceptives Market 2017-2023 - The Market is Dominated by Allergan Plc, Bayer AG, Merck & Co., Teva Pharmaceutical, and Church & Dwight
Nov 28, 2017
ImmunoMet Appoints Briggs W. Morrison, M.D., and Paul Lammers, M.D., M.Sc., to Board of Directors
Nov 21, 2017
Bayer® Aspirin's "HeroSmiths" Campaign Awarded CHPA's Prestigious Industry Leadership Award For Advancing Responsible Self-Care
Oct 02, 2017
SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA
Sep 12, 2017
Berkeley Lights Announces Strategic Project with Bayer Focused on Cell Line Development and Antibody Discovery
Sep 11, 2017
Bayer and Vanderbilt University Medical Center collaborate to develop new therapies against kidney diseases
Aug 22, 2017
TARA Biosystems Appoints Pharmaceutical Industry Leader, Michael P. Graziano, Ph.D., as Chief Scientific Officer
Jul 26, 2017
Compugen Discloses Updates to Collaborative Activities with Bayer in Immuno-Oncology
May 29, 2017
Research and Markets - Renal Cluster Drug Development Pipeline Review 2017 - Key Companies are Angion Biomedica, Apceth Biopharma, AstraZeneca, Bayer, Evotec, Novartis, Sarfez Pharmaceuticals & Vidasym